DOCTEUR BLAISE KOVACS
The computed 12-month bankruptcy probability of DOCTEUR BLAISE KOVACS is 1.8% (moderate). The 2025 annual accounts show equity of €21k and a net result of €17k. Equity is shrinking by ~34.6% per year and would, assuming unchanged policy, indicatively turn negative around fiscal year 2028. The company has been active since 2007 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €21k |
| Net result | €17k |
| Active | 19 yrs |
Strong profile, led by profitability.
All 5 axes are computed from data Checked has read.
The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
Figures by fiscal year and ratios
| Fiscal year | 2025 |
|---|---|
| Deposit | micro schema |
| Revenue | - |
| EBITDA | €26k |
| Net profit | €17k |
| Cash flow | €22k |
| Staff costs | - |
| Income taxes | €3k |
| Dividends | - |
| Total assets | €63k |
| Equity | €21k |
| Debt | €43k |
| of which ≤ 1y | €43k |
| of which > 1y | - |
| Working capital | €-38k |
| Employees (FTE) | - |
| 2025 | |
|---|---|
| Current ratio | 0.11 |
| Quick ratio | 0.11 |
| Working capital ratio | -59.9% |
| Solvency | 32.5% |
| Debt / equity | 2.07 |
| Long-term debt ratio | - |
| Interest coverage | 41.12 |
| Gross margin | - |
| Net margin | - |
| ROA | 27.2% |
| ROE | 83.5% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Full annual accounts (20 line items)
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €63k |
| Fixed assets | 21/28 | €58k |
| Intangible fixed assets | 21 | €1 |
| Tangible fixed assets | 22/27 | €58k |
| Current assets | 29/58 | €5k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €63k |
| Equity | 10/15 | €21k |
| Reserves | 13 | €23k |
| Accumulated profits (losses) | 14 | €-2k |
| Amounts payable | 17/49 | €43k |
| Amounts payable within one year | 42/48 | €43k |
| Trade debts payable within one year | 44 | €4k |
| Income statement | ||
| Gross operating margin | 9900 | €27k |
| Operating result | 9901 | €21k |
| Financial income | 75 | €6 |
| Financial charges | 65 | €637 |
| Result before taxes | 9903 | €20k |
| Income taxes | 67/77 | €3k |
| Net result for the period | 9904 | €17k |
| Result to be appropriated | 9905 | €17k |
| NACE primary | - |
| Legal form | Private limited company(610) |
| Incorporation | 26-06-2007 |
| Status | Active |
| Postal code | 1190 |
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21007A0117/00P003 | Brussels | 111 m² | 1 · 104 m² | 12.5 m · 3 fl. |
30-06-2026 NBB filing Annual accounts filed
26-08-2025 NBB filing Annual accounts filed
20-08-2024 NBB filing Annual accounts filed
11-07-2023 NBB filing Annual accounts filed
01-12-2022 NBB filing Annual accounts filed
28-09-2021 NBB filing Annual accounts filed
26-11-2020 NBB filing Annual accounts filed
26-02-2020 NBB filing Annual accounts filed
31-08-2018 NBB filing Annual accounts filed
13-09-2017 NBB filing Annual accounts filed
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
| Legal nameFR | DOCTEUR BLAISE KOVACS |